Healthcare-associated infections (HAIs) continue to be a leading cause of morbidity, mortality, and increased healthcare costs worldwide. Despite advances in infection prevention, the burden of HAIs remains high, exacerbated by the rise of antimicrobial resistance (AMR) and the growing complexity of patient care. Effective prevention strategies are critical to reducing HAI rates and improving patient outcomes. This review aims to highlight the clinical significance of HAIs, explore their impact on patient safety, and underscore the necessity for robust surveillance and infection control (IC) programs across healthcare settings.The study found that HAIs continue to affect a significant proportion of hospitalized patients, with invasive devices and antimicrobial-resistant pathogens being key contributors. Surveillance systems, when combined with targeted IC protocols and continuous staff education, can reduce HAI incidence and improve patient safety. Moreover, the implementation of antimicrobial stewardship programs and proper hygiene practices along with emerging technologies plays a pivotal role in curbing the spread of resistant organisms.Healthcare systems must prioritize HAI prevention to safeguard patient safety, reduce treatment costs, and combat the growing threat of AMR.